Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF–induced thermoablative therapy for human breast cancer in mice

SJ DeNardo, GL DeNardo, A Natarajan… - Journal of Nuclear …, 2007 - Soc Nuclear Med
Antibody (mAb)-linked iron oxide nanoparticles (bioprobes) provide the opportunity to
develop tumor specific thermal therapy (Rx) for metastatic cancer when inductively heated …

Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy

SJ DeNardo, GL DeNardo, LA Miers, A Natarajan… - Clinical cancer …, 2005 - AACR
Abstract Objectives: 111In-chimeric L6 (ChL6) monoclonal antibody (mAb)–linked iron oxide
nanoparticle (bioprobes) pharmacokinetics, tumor uptake, and the therapeutic effect of …

Biocompatible nanoclusters with high heating efficiency for systemically delivered magnetic hyperthermia

HA Albarqi, LH Wong, C Schumann, FY Sabei… - ACS …, 2019 - ACS Publications
Despite its promising therapeutic potential, nanoparticle-mediated magnetic hyperthermia is
currently limited to the treatment of localized and relatively accessible cancer tumors …

[HTML][HTML] High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area

S Kossatz, R Ludwig, H Dähring, V Ettelt… - Pharmaceutical …, 2014 - Springer
Purpose Tumor cells can be effectively inactivated by heating mediated by magnetic
nanoparticles. However, optimized nanomaterials to supply thermal stress inside the tumor …

Development of multivalent radioimmunonanoparticles for cancer imaging and therapy

A Natarajan, CY Xiong, C Gruettner… - Cancer biotherapy & …, 2008 - liebertpub.com
Background: Noninvasive, focused hyperthermia can be achieved by using an externally
applied alternating magnetic field (AMF) if effective concentrations of nanoparticles can be …

Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles

A Chauhan, S Midha, R Kumar, R Meena… - Biomaterials …, 2021 - pubs.rsc.org
Among conventional cancer therapies, radio-frequency magnetic hyperthermia (MHT) has
widely been investigated for use with magnetic nanoparticles (MNPs). However, the majority …

[HTML][HTML] Micron-sized iron oxide particles for both MRI cell tracking and magnetic fluid hyperthermia treatment

L Dallet, D Stanicki, P Voisin, S Miraux, EJ Ribot - Scientific reports, 2021 - nature.com
Iron oxide particles (IOP) are commonly used for Cellular Magnetic Resonance Imaging
(MRI) and in combination with several treatments, like Magnetic Fluid Hyperthermia (MFH) …

[HTML][HTML] Biologically targeted magnetic hyperthermia: Potential and limitations

D Chang, M Lim, JACM Goos, R Qiao, YY Ng… - Frontiers in …, 2018 - frontiersin.org
Hyperthermia, the mild elevation of temperature to 40–43° C, can induce cancer cell death
and enhance the effects of radiotherapy and chemotherapy. However, achievement of its full …

[HTML][HTML] Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug …

S Kossatz, J Grandke, P Couleaud, A Latorre… - Breast Cancer …, 2015 - Springer
Introduction Tumor cells can effectively be killed by heat, eg by using magnetic
hyperthermia. The main challenge in the field, however, is the generation of therapeutic …

Physical and biological properties of 5-fluorouracil polymer-coated magnetite nanographene oxide as a new thermosensitizer for alternative magnetic hyperthermia …

L Kiamohammadi, L Asadi, S Shirvalilou, S Khoei… - ACS …, 2021 - ACS Publications
This study reports a new procedure for utilizing 5-fluorouracil (5-Fu)-loaded
polycaprolactone (PCL)/chitosan-covered magnetite nanographene oxide (5 …